Loading clinical trials...

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT02494024

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

This study will evaluate the safety and tolerability (maximum tolerated dose (MTD) within the specified dosing range) of single intravenous (IV) infusion of C2N-8E12 in patients with progressive supra...

Lead sponsor: C2N Diagnostics•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Synaptic Loss in Multiple System Atrophy

NCT05121012 · Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)

RECRUITING

UPenn Observational Research Repository on Neurodegenerative Disease

NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more

RECRUITINGNA

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more

RECRUITINGNA

The Swedish BioFINDER 2 Study

NCT03174938 · Dementia, Alzheimer Disease, and more

RECRUITINGPhase 2

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

NCT06162013 · Progressive Supranuclear Palsy, Multiple System Atrophy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 26, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment32

Start dateJul 2015

Last updatedJul 26, 2017

Condition

Progressive Supranuclear Palsy

Locations shown

University of Alabama

Birmingham, Alabama

Mayo Clinic

Scottsdale, Arizona

University of California, Los Angeles (UCLA)

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 26, 2017Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions